Impact of preexisting coronary artery and peripheral artery disease on outcomes in diabetic patients after kidney transplant

• Published in: Vascular medicine (London, England) Vol. 29; no. 2; p. 135
• Main Authors: Jiwani, Sania, Chan, Wan-Chi, Majmundar, Monil, Patel, Kunal N, Mehta, Harsh, Sharma, Aditya, Parmar, Gaurav, Wiley, Mark, Tadros, Peter, Hockstad, Eric, Yarlagadda, Sri G, Gupta, Aditi, Gupta, Kamal
• Format: Journal Article
• Language: English
• Published: England 01.04.2024
• Subjects: coronary artery disease (CAD); diabetes mellitus; end-stage kidney disease; kidney transplantation; peripheral artery disease (PAD)
• ISSN: 1477-0377
• DOI: 10.1177/1358863X231205574

Atherosclerotic cardiovascular disease is highly prevalent in patients with end-stage kidney disease (ESKD). Kidney transplant (KT) improves patient survival and cardiovascular outcomes. The impact of preexisting coronary artery disease (CAD) and peripheral artery disease (PAD) on posttransplant outcomes remains unclear. This is a retrospective study utilizing the United States Renal Data System. Adult diabetic dialysis patients who underwent first KT between 2006 and 2017 were included. The study population was divided into four cohorts based on presence of CAD/PAD: (1) polyvascular disease (CAD + PAD); (2) CAD without PAD; (3) PAD without CAD; (4) no CAD or PAD (reference cohort). The primary outcome was 3-year all-cause mortality. Secondary outcomes were incidence of posttransplant myocardial infarction (MI), cerebrovascular accidents (CVA), and graft failure. The study population included 19,329 patients with 64.4% men, mean age 55.4 years, and median dialysis duration of 2.8 years. Atherosclerotic cardiovascular disease was present in 28% of patients. The median follow up was 3 years. All-cause mortality and incidence of posttransplant MI were higher with CAD and highest in patients with polyvascular disease. The cohort with polyvascular disease had twofold higher all-cause mortality (16.7%, adjusted hazard ratio (aHR) 1.5, < 0.0001) and a fourfold higher incidence of MI (12.7%, aHR 3.3, < 0.0001) compared to the reference cohort (8.0% and 3.1%, respectively). There was a higher incidence of posttransplant CVA in the cohort with PAD (3.4%, aHR 1.5, = 0.01) compared to the reference cohort (2.0%). The cohorts had no difference in graft failure rates. Preexisting CAD and/or PAD result in worse posttransplant survival and cardiovascular outcomes in patients with diabetes mellitus and ESKD without a reduction in graft survival.